business

Dr Reddy's Miryalaguda facility gets 3 USFDA observations

Drug firm Dr Reddy's Laboratories today said the US health regulator has made three observations after completing inspection of its Miryalaguda facility.

first published: Feb 21, 2017 09:10 pm

LATEST VIDEOS

Watch More →

A collection of the most-viewed Moneycontrol videos.

Nifty Aims For Next 26,100 After Hitting 3-Week High |Opening Bell Live
Nifty Back Above 26,000 As IT Stocks Sprint Ahead; Nvidia Earnings In Focus| Closing Bell Live
Redefining Distribution with Next-Gen Technology Solutions
Leveraging Technology to Build Scale: Transforming the Mutual Fund Industry

Watch and Follow our leading shows

Newspresso Live
Morning Trade
Opening Bell
Mid-day Mood Check
Commodities Live
Closing Bell
Bajar Gupshup
Managing Market Turns

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347